ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,663.92
      1.34%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Leap Therapeutics Inc (LPTX)

      7. Leap Therapeutics Inc (LPTX) News

      LPTX

      Leap Therapeutics (LPTX)

      Leap Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPTX
      DateTimeSourceHeadlineSymbolCompany
      12/14/20187:00AMPR Newswire (US)Leap Therapeutics Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tr...NASDAQ:LPTXLeap Therapeutics Inc
      11/19/20185:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/09/20187:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/09/20187:05AMPR Newswire (US)Leap Therapeutics Reports Third Quarter 2018 Business Update and Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      11/09/20187:03AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      11/09/20187:00AMPR Newswire (US)Leap Therapeutics Presents Esophagogastric Cancer Data at SITC 2018 Annual MeetingNASDAQ:LPTXLeap Therapeutics Inc
      10/22/20188:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      10/21/20186:45AMPR Newswire (US)Leap Therapeutics Presents Esophagogastric Cancer Data at ESMO 2018 Annual CongressNASDAQ:LPTXLeap Therapeutics Inc
      10/08/20186:35PMPR Newswire (US)Leap Therapeutics to Present Data from Study Evaluating DKN-01 in Combination with KEYTRUDA® (pembrolizumab) at the European...NASDAQ:LPTXLeap Therapeutics Inc
      09/25/20187:00AMPR Newswire (US)Leap Therapeutics to Present at Two October ConferencesNASDAQ:LPTXLeap Therapeutics Inc
      09/10/20184:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LPTXLeap Therapeutics Inc
      09/07/20184:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      09/07/20184:45PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:LPTXLeap Therapeutics Inc
      08/30/20184:05PMPR Newswire (US)Leap Therapeutics to Participate in the H.C. Wainwright 20th Annual Global Investment ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      08/13/20185:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/08/20187:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      08/08/20187:00AMGlobeNewswire Inc.Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      08/08/20186:54AMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:LPTXLeap Therapeutics Inc
      08/08/20186:53AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      08/01/20187:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      07/23/20187:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      07/23/20187:30AMGlobeNewswire Inc.Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, ...NASDAQ:LPTXLeap Therapeutics Inc
      06/13/20187:00AMGlobeNewswire Inc.Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      05/11/20187:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LPTX

      Your Recent History

      BOV
      MTSA4Q
      METISA PN
      Delayed Upgrade Clock